Anhedonia in the structure of post-COVID syndrome in psychiatric inpatients: the probable role of obesity, systemic inflammation, vascular disregulation and general therapeutic comorbidity

COVID-19 caused not only acute but also delayed neuropsychiatric disorders. A highly probable manifestation of the latter may be physical anhedonia, since this transnosological psychopathological phenomenon is associated with a violation of metabolic and neuroinflammatory processes. The goal. To identify the prevalence of physical anhedonia in the clinic of post-COVID syndrome and to assess the association of this transnosological psychopathological symptom with concomitant somatic burden, the severity of the SARS-CoV-2 infection and the time elapsed since the disease. Materials and Methods. The prevalence of acute and delayed neuropsychiatric symptoms was assessed in 48 psychiatric inpatients with severe mental disorders depending on the history of COVID-19. Quantitative and qualitative assessment was carried out by self-reporting on the number of simultaneously present groups of chronic diseases, and the severity of obesity was objectively assessed - by body mass index, dysregulation of vascular tone-by blood pressure variability, systemic inflammation - by sed rate and platelet-lymphocyte ratio (PLR). Physical anhedonia was detected using the Russian-language version of the Revised physical anhedonia scale (RPAS). Results. The association between the severity of COVID-19 and the severity of anhedonia, as a probable component of post-COVID syndrome, was confirmed. The total general therapeutic burden was the most important predictor of acute and delayed neuropsychiatric symptoms against the background of COVID-19. The probable role of metabolic syndrome, systemic inflammation and vascular tone was shown in the development of late disorders after coronavirus infection. Conclusion. The role of general therapeutic burden (including obesity, vascular dysregulation and systemic inflammation) in the development of anhedonia in patients with mental disorders who have had COVID-19 has been demonstrated.

1. Krylov VI. Anhedonia affective and schizophrenia spectrum disorders: psychopathological features, diagnostic and prognostic value. Psihiatriya i psihofarmakoterapiya. 2014;1:28-33. (In Russ.).

2. Lutova NB, Khobeysh MA, Makarevich OV, Bocharova MO, Gerasimchuk ES, Sorokin MYu. Adaptation and validation of the Physical Anhedonia Scale (Revised Physical Anhedonia Scale): psychometric properties of the Russian-speaking methodology. Psihiatriya i psihofarmakoterapiya. 2024;4:25-34. https://doi.org/10.62202/2075-1761-2024-26-4-25-34. (In Russ.).

3. Mazo GE, Kibitov AO. Anhedonia as a basic syndrome and a target for treatment for depressive disorder. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva. 2019;(3):10-18. https://doi.org/10.31363/2313-7053-2019-3-10-18. (In Russ.).

4. Mendelevich VD, Gatin FF, Khamitov RR. What did the COVID-19 epidemic learn psychiatrists? Nevrologicheskij vestnik. 2023;(4):5-13. https://doi.org/10.17816/nb117637 (In Russ.).

5. Mendelevich EG, Saifeeva AA, Kurbanov AI. COVID-19-associated orthostatic hypotension syndrome: direct and indirect mechanisms of development. Nevrologicheskij vestnik. 2021;(3):64-70. https://doi.org/10.17816/nb81629 (In Russ.).

6. Mendelevich VD. Understanding of anhedonia: from traditional to phenomenological analysis of the phenomena. Nevrologicheskij vestnik. 2021;(3):44-50. https://doi.org/10.17816/nb78185. (In Russ.).

7. Neznanov NG, Limankin OV, Shabelnik AV, Azarova LA, Lutova NB, Bocharova MO, Sorokin MYu. Psychopharmacotherapy factor in the variants of COVID-19 course in psychiatric inpatients. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva. 2024;58(2):79-88. https://doi.org/10.31363/2313-7053-2024-856. (In Russ.).

8. Neznanov NG, Sorokin MYu, Skripov VS, Esina KM. Epidemiology of mental disorders as a marker of psychiatric factors of the COVID-19 pandemic. Rossiiskii psikhiatricheskii zhurnal. 2023;(1):4–13. (In Russ.).

9. Sorokin MYu. Affective and cognitive symptoms in COVID-19 survivors: implications for organization of psychiatric services in the post pandemic and within pandemic period. Byulleten’ medicinskoĭ nauki. 2022;3(27):117-127. (In Russ.).

10. Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological Sequelae of COVID-19. J Integr Neurosci. 2022;21(3):77. https://doi.org/10.31083/j.jin2103077.

11. AlJameel AH, AlSaleh LS, Bawazir NH, AlOmair AS, Almalki SA. How Mental Health Correlates with Subjective Oral Health Status: A Cross-Sectional Study among a Group of University Students. Niger J Clin Pract. 2023;26(11):1716-1722. https://doi.org/10.4103/njcp.njcp_330_23

12. AlShakhs A, Almomen A, AlYaeesh I, et al. The Association of Smell and Taste Dysfunction with COVID19, And Their Functional Impacts. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):2847-2852. https://doi.org/10.1007/s12070-020-02330-w

13. Amin V, Flores CA, Flores-Lagunes A. The impact of BMI on mental health: Further evidence from genetic markers. Econ Hum Biol. 2020;38:100895. https://doi.org/10.1016/j.ehb.2020.100895

14. Bisaccia G, Ricci F, Recce V, et al. Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?. J Cardiovasc Dev Dis. 2021;8(11):156. https://doi.org/10.3390/jcdd8110156

15. Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63-e67. https://doi.org/10.7861/clinmed.2020-0896

16. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recom- mendations. Nat Rev Microbiol. 2023;21(3):133- 146. https://doi.org/10.1038/s41579-022-00846-2

17. El Sayed S, Shokry D, Gomaa SM. Post-COVID-19 fatigue and anhedonia: A cross-sectional study and their correlation to post-recovery period. Neuropsychopharmacol Rep. 2021;41(1):50-55. https://doi.org/10.1002/npr2.12154

18. Fleischer E, Landaeta-Díaz L, González-Medina G, Horovitz O. Anxiety, anhedonia, and related food consumption in Israelis populations:An online cross-sectional study two years since the outbreak of COVID-19. Heliyon. 2023;9(6):e17211. https://doi.org/10.1016/j.heliyon.2023.e17211

19. Gomzyakova N, Palchikova E, Tumova M, Kasyanov E, Sorokin M. Association of Anxiety and Depression with Objective and Subjective Cognitive Decline in Outpatient Healthcare Consumers with COVID-19: А Cross-Sectional Study. Consort Psychiatr. 2022;3(3):45-55. https://doi.org/10.17816/CP189

20. Gouraud C, Bottemanne H, Lahlou-Laforêt K, et al. Association Between Psychological Distress, Cognitive Complaints, and Neuropsychological Status After a Severe COVID-19 Episode: A Cross-Sectional Study. Front Psychiatry. 2021;12:725861. https://doi.org/10.3389/fpsyt.2021.725861

21. Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci. 2018;19(8):470-484. https://doi.org/10.1038/s41583-018-0029-9

22. Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its Management. Int J Biol Sci. 2022;18(12):4768-4780. https://doi.org/10.7150/ijbs.75056.

23. Ly M, Yu GZ, Mian A, et al. Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer’s disease, and Depression. Am J Geriatr Psychiatry. 2023;31(10):853-866. https://doi.org/10.1016/j.jagp.2023.06.001.

24. Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484-3496. https://doi.org/10.1016/j.neuron.2022.10.006.

25. Moustafa IM, Ahbouch A, Kader RP, Shousha TM, Alrahoomi A. A Comparison of Sensorimotor Integration and Motor Fitness Components between Collegiate Athletes with and without Long COVID: A Cross-Sectional Study with Pair-Matched Controls. J Clin Med. 2024;13(9):2469. https://doi.org/10.3390/jcm13092469.

26. Seon JY, Kim S, Hong M, Lim MK, Oh IH. Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study. Epidemiol Psychiatr Sci. 2021;30:e68. https://doi.org/10.1017/S2045796021000597.

27. Sorokin M, Markin K, Kibitov A, Palchikova E, Zubova E. The Mind-Body Problem in the Context of Neuropsychiatric Symptoms in Patients with Coronavirus Disease 2019. Alpha Psychiatry. 2023;24(6):257-260. https://doi.org/10.5152/alphapsychia-try.2023.231178.

28. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic [who.int]. who; 2024. Available: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.

29. Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890. https://doi.org/10.1177/20406223221076890.

30. Walker VM, Patalay P, Cuitun Coronado JI, et al. COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People. JAMA Psychiatry. 2024:e242339. https://doi.org/10.1001/jamapsychiatry.2024.2339.